A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Recruiting

Phase 1

Phase 2

BMS-986470A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Sponsor:

Bristol-Myers Squibb

Code:

NCT06481306

Conditions

Anemia, Sickle Cell

Healthy Volunteers

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

BMS-986470

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Bristol-Myers Squibb on 2025-05-28.